FAST (Foundation for Angelman Syndrome Therapeutics): FAST and SFARI to launch International Angelman Syndrome Research Council (INSYNC-AS)
DOWNERS GROVE, Ill., Feb. 19, 2021 (GLOBE NEWSWIRE) -- FAST (
Foundation for Angelman Syndrome Therapeutics) and the
Simons Foundation Autism Research Init
iative (SFARI) today announced a collaboration to launch the
International Angelman Syndrome Research Council (INSYNC-AS). Using a robust integrated approach, the Council will evaluate and drive research initiatives in Angelman syndrome (AS) and other neurodevelopmental disorders (NDDs).
INSYNC-AS's goal is to build community and leverage the combined skills of world leaders in neuroscience, clinical research, genetics, drug development, regulatory expertise, and other thought leaders, in order to accelerate drug development for Angelman syndrome and other related disorders. The Council was formed to be an innovative model that encourages research in areas where gaps need to be filled. A multi-functional combination of skill sets and expertise will help to advance FAST's deep funding strategies, while leveraging these learnings to other NDDs.